Metro Preclinical Consulting, LLC
Metro Preclinical Consulting, LLC, founded in 2024 and based in New Jersey, USA, provides comprehensive support to medtech companies in the strategy and execution of preclinical evidence generation. The company offers a tailored approach to maximize data while minimizing animal use in preclinical development programs, supporting product research and regulatory filings. Metro Preclinical is committed to being a responsive, diligent, and candid partner, guiding products from concept to clinic.
Metro Preclinical Consulting, LLC
What We Do
Includes preclinical testing plan tailored to goals, GLP and non-GLP in vivo testing, animal model selection and refinement, research and clinical surgical expertise, and biocompatibility testing programs.
Involves CRO due diligence and selection, protocol development, study oversight, review of study reports, and relationship management with CROs and scientists.
Covers FDA pre-submission preparation, preclinical data summaries for regulatory filings, and creation of peer-reviewed publications and technical documents.
Includes review and appraisal of preclinical data and regulatory gap assessments.
Offers technical training, KOL/scientific advisor identification, and research and business grant application support.
Key People
Owner and Principal Consultant